mvTool — A New, One-stop Resource for Clinicians and Researchers Published on Jun 18, 2018 in CHOP News Clinicians and researchers in mitochondrial disease now can access a new, one-stop bioinformatics tool that collects annotated data on mitochondrial DNA (mtDNA) variants.
What Would Help or Hinder Patients Joining Clinical Trials for Mitochondrial Disease? Published on Jun 06, 2018 in CHOP News As clinical trials aim to attain the first FDA-approved treatments for mitochondrial disease, a study reports patient and family preferences.
Mitochondrial Medicine Team Participates in Annual Research Affinity Group Retreat Published on Jun 05, 2018 in CHOP News Participants discussed advancements in the mitochondrial medicine field, attended seminars, participated in team-building activities, and created further collaborative opportunities.
Three Extraordinary Programs Are Envisioning the Breakthroughs of Tomorrow Published on May 11, 2018 in Children's View Three Frontier Programs (NeoCLD Program, Mitochondrial Medicine, and Pediatric Airway Disorders) have made world-changing discoveries, delivered lifesaving therapies, and provided exceptional care.
In Lab Tests, Antioxidants Show Promise in Treating Mitochondrial Disease Published on Mar 27, 2018 in CHOP News Systematic laboratory studies find some antioxidants should be tested in clinical trials as treatments for patients with mitochondrial disease.
Intravenous Arginine Benefits Children after Acute Metabolic Strokes Published on Mar 09, 2018 in CHOP News Children with mitochondrial diseases who suffered acute metabolic strokes benefited from rapid IV treatment with the amino acid arginine, with no side effects.
Making Ben — and Janssen — Proud Published on Jan 30, 2018 in Breakthrough Report Douglas Wallace, PhD, is considered the founder of mitochondrial genetics. His groundbreaking research at CHOP earned him two prestigious international awards in 2017.
Can Vitamins and Supplements Help Patients with Mitochondrial Disease? Published on Jan 11, 2018 in CHOP News Lacking effective drug treatments, patients with mitochondrial disease may use many vitamins and supplements — most of which are unregulated and untested.
Children's Hospital of Philadelphia Celebrates FDA Approval of Gene Therapy for Inherited Blindness Published on Dec 19, 2017 in CHOP News A breakthrough therapy has its genesis in more than 10 years of research conducted at Children's Hospital of Philadelphia.
The Pennsylvania Gazette Features Mitochondrial Medicine Patient Published on Dec 19, 2017 in CHOP News The Pennsylvania Gazette featured CHOP’s Mitochondrial Medicine’s translational research efforts to partner with families and identify precision medicines for rare diseases.
